GIM
EW icon

Generali Investments Management’s Edwards Lifesciences EW Stock Holding History

Generali Investments Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$555K Hold
6,140
– – 0.12% 101
2026
Q1 		$492K Sell
6,140
-1,420
-19% -$117K 0.11% 111
2025
Q4 		$644K Hold
7,560
– – 0.13% 100
2025
Q3 		$588K Buy
+7,560
New +$591K 0.12% 110

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Generali Investments Management's EW Position: Q2 2026 in Review

Generali Investments Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 6,140 shares worth $555K. The position accounts for 0.12% of the portfolio, ranked #101.

Generali Investments Management first reported a position in EW in Q3 2025 and has held it in 4 quarters since. The position peaked at $644K in Q4 2025. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Generali Investments Management held 6,140 shares of Edwards Lifesciences worth $555K as of Q2 2026.
  • Generali Investments Management left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.12% of Generali Investments Management's portfolio in Q2 2026, its #101 holding.
  • Generali Investments Management first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 4 quarters since.
  • Generali Investments Management's Edwards Lifesciences position peaked at $644K in Q4 2025.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.